|
Article ID: 699140 University of California, Los Angeles (UCLA), Health SciencesResearchers have found that cholesterol-lowering statins may improve the conditions of people with a rare lung disease called autoimmune pulmonary alveolar proteinosis. The research also suggested that two new tests could help diagnose the condition. |
Article ID: 699129 George Washington UniversityResearchers from the George Washington University published an article in Trends in Parasitology outlining their lessons learned while creating vaccine candidates for hookworm and schistosomiasis. Channels: Dermatology, Liver Disease, Pharmaceuticals, Poverty, Vaccines, Local - DC, Local - DC Metro, All Journal News GW School of Medicine and Health Sciences, Tropical Medicine, travel health, diseases of poverty, Vaccines, Vaccine Development, Hookworm, Schistosomiasis, Liver Flukes, Global Medicine, Disease In The Developing World |
Embargo will expire:21-Aug-2018 8:00 AM EDTReleased to reporters:16-Aug-2018 3:05 PM EDT |
|
Article ID: 699127 Stony Brook MedicineIsland Fertility has joined Stony Brook Community Medical, expanding to 23 the number of Stony Brook Medicine’s network of community practices and physicians. |
|
Article ID: 699122 Case Western Reserve UniversityA multidisciplinary research team led by Case Western Reserve University School of Medicine has received a three-year, $936,000 grant to use collaborative computational modeling approaches to promote better community health through more equitable food systems. Channels: Food Science, Health Food, Healthcare, Nutrition, Pharmaceuticals, Local - Ohio Case Western Reserve University, Case Western Reserve University School Of Medicine, Foundation for Food and Agriculture Research, Cleveland, food systems, Public Health, darcy freedman, emergency food assistance programs, supermarket expansion, social marketing, Nutrition, Sustainability |
Embargo will expire:21-Aug-2018 11:00 AM EDTReleased to reporters:16-Aug-2018 2:00 PM EDT |
|
Article ID: 699107 Missouri University of Science and Technology“High risk, high reward” is the kind of discovery Dr. Garry Grubbs seeks with a new experiment designed to rapidly identify the atomic structure of chiral molecules widely used in pharmaceutical drugs. The finding could significantly reduce the time and costs involved in pharmaceutical development and manufacturing. Channels: Cell Biology, Chemistry, Pharmaceuticals, Technology, Grant Funded News chiral molecules, discernment of chiral molecules, pharmaceutical development, Drug Development, advanced microwave spectroscopy, Missouri University of Science and Technology, Missouri S&T, experimental identification of chirality, Pharmaceutical Industry, identification of chiral molecules, atomic structure of chiral molecules |
|
Article ID: 699083 Johns Hopkins MedicineResearchers in the Department of Physical Medicine and Rehabilitation at Johns Hopkins Medicine report that a computerized study of 36 healthy adult volunteers asked to repeat the same movement over and over became significantly faster when asked to repeat that movement on demand—a result that occurred not because they anticipated the movement, but because of an as yet unknown mechanism that prepared their brains to replicate the same action. |
Article ID: 699041 University of North Carolina Health Care SystemResearchers discovered a gene mutation underlying hydrops fetalis – a fatal condition to fetuses. The proteins at the center of this finding are implicated in a number of diseases, opening avenues of potential drug discovery related to migraines, diabetes, osteoporosis, and other conditions. |
Article ID: 699039 University of New Mexico Comprehensive Cancer CenterNeuroendocrine cancer is rare and hard to diagnose – and it can be difficult to treat and to survive. To help make more accurate diagnoses more quickly, the UNM Department of Radiology recently started using a new, injectable imaging agent to pinpoint neuroendocrine tumors. And in October, UNM Cancer Center will begin offering a new treatment that uses part of that imaging agent to fight the tumors. |